Needham cuts Alkami Technology target price to $20 from $25
ALKT•Needham cut its target price for Alkami Technology to $20 from $25.
Related News
NeuroOne's OneRF delivers immediate pain relief in 14 of 15 patients in initial study
NMTC•
Medical Properties Trust Q3 revenue rises
MPW•
BorgWarner wins inverter supply contract for global automaker's future electric vehicles
BWA•
FDA clears Eloxx's Exaluren for Phase 2 trial in ADPKD
ELOX•
Annovis Bio participates in U.S. Biotech Day and Pharma Partnering Summit
ANVS•